A CLINICAL STUDY OF SIDDHA HERBAL PREPARATION – M V KASHAYAM FOR THE TREATMENT, CONTROL, AND MANAGEMENT OF COVID-19

  • MALARKANNAN SP Department of Rural Development Science, Arul Anandar College, Madurai, Tamil Nadu, India.
  • DHARUMARAJAN P Department of Indian Medicine and Homeopathy, Government Hospital, Virudhunagar, Tamil Nadu, India.
  • HARIYOHESH MK Medical School Foundation, BS MD Scholar, Daevo Medical School Foundation Inc, Medical School Dr, Poblacion district, Davo City, 8000 Davo del Sur, Philippines.

Abstract

Objective: At present, the pandemic COVID-19 by novel coronavirus causing severe mortality and losses to the human and no specific medicine to cure. Siddha is an ancient system of medicine used in using a variety of medicinal herbs to cure diseases of viral and unknown origin.


Method: The herbal medicine M V Kashayam prepared as per Siddha formula administered at the dose rate of 150 ml for every 6-h interval for Reverse Transcription–Polymerase Chain Reaction (RT – PCR) positive patients


Results: The prepared MV Kashayam can able to provide RT-PCR negative in 87.5% of cases within 4–6 days and 97.5% negatives in 12 days. The body temperature, Oxygen saturation level (SPO2), and respiration level become normal within 3 days.


Conclusion: The Siddha medicine, MV kashayam may be used as herbal medicine to treat the COVID-19 patients for earlier recovery and as a preventive measure to enhance immunity.

Keywords: COVID, Siddha preparation, MV kashayam, Treatment

Author Biography

DHARUMARAJAN P, Department of Indian Medicine and Homeopathy, Government Hospital, Virudhunagar, Tamil Nadu, India.

Assistant Siddha Medical Officer,

Government Hospital,

Aruppukottai,

Virudhunagar Dist, Tamil Nadu.

Mob: 9442581332 E-Mail: harsanasiddhamm@gmail.com

References

1. Kartikeyan J, Rekha V,Giftson RV. Characterization of bioactive compounds in Costus speciosus (Koen.) by reverse-phase HPLC. Int J Pharm Sci Res 2012;3:1461-5.
2. Thomas J. Medicinal and Aromatic Plant Research in India. In: Training Course on Industrial Exploitation of Indigenous Medicinal and Aromatic Plants. Beijing, China: UNDP, Proceeding; 1997. p. 17-27.
3. Panda D, Kumar DS, Kumar DG. Phytochemical examination and antimicrobial activity of various solvent extracts and the selected isolated compounds from roots of Tragia involucrata Linn. Int J Pharm Sci Drug Res 2012;4:44-8.
4. Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol 2016;3:237-61.
5. Yousef A, Sepandi M, Taghdir M, Hosamirudsari H. Determine the most common clinical symptoms in COVID-19 patients: A systematic review and meta-analysis. J Prev Med Hyg 2020;61:E304-12.
6. Malarkannan SP, Dharumaraj P. Anti-inflammatory activity of siddha preparation modivaer kashayam as a proposed remedy for management and treatment of Covid 19. Int J Res Anal Rev 2020;7:756-9.
7. Gupta SP. Statistical Methods. New Delhi: Sulthan Chand and Sons; 1997.
8. Jun Mi, Zhong W, Huang C, Zhang W, Tan L, Ding L. Gender, age and comorbidities as the main prognostic factors in patients with COVID-19 pneumonia. Am J Transl Res 2020;12:6537-48.
9. Preas HL, Jubran A, Vandivier RW, Reda D, Godin PJ, Banks SM, et al. Effect of endotoxin on ventilation and breath variability: Role of the cyclooxygenase pathway. Am J Respir Crit Care Med 2001;164:620-6.
10. Tobin MJ. Basing respiratory management of COVID-19 on physiological principles. Am J Respir Crit Care Med 2020;201:1319- 20.
11. Mark RG, David AG. Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality, Med Hypotheses 2020;40:109760.
12. Arjun R, Duraisamy AJ, Selvakumar B, Pal SV. Medicinal plants from Siddha system of medicine useful for treating respiratory diseases. Int J Pharm Anal 2009;1:20-30.
Statistics
10 Views | 10 Downloads
Citations
How to Cite
SP, M., D. P, and H. MK. “A CLINICAL STUDY OF SIDDHA HERBAL PREPARATION – M V KASHAYAM FOR THE TREATMENT, CONTROL, AND MANAGEMENT OF COVID-19”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 14, no. 6, Apr. 2021, pp. 104-7, doi:10.22159/ajpcr.2021.v14i6.41582.
Section
Original Article(s)